help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoos, A.
Right arrow Articles by Cordon-Cardo, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoos, A.
Right arrow Articles by Cordon-Cardo, C.
(American Journal of Pathology. 2001;158:1245-1251.)
© 2001 American Society for Investigative Pathology

Short Communications

Validation of Tissue Microarrays for Immunohistochemical Profiling of Cancer Specimens Using the Example of Human Fibroblastic Tumors

Axel Hoos*, Marshall J. Urist{dagger}, Alexander Stojadinovic*, Stephen Mastorides{dagger}, Maria E. Dudas{dagger}, Denis H. Y. Leung{ddagger}, David Kuo{dagger}, Murray F. Brennan*, Jonathan J. Lewis* and Carlos Cordon-Cardo{dagger}

From the Departments of Pathology,{dagger}
Surgery,*
and Biostatistics,{ddagger}
Memorial Sloan-Kettering Cancer Center, New York, New York

Tissue microarrays allow high-throughput molecular profiling of cancer specimens by immunohistochemistry. Phenotype information of sections from arrayed biopsies on a multitissue block needs to be representative of full sections, as protein expression varies throughout the entire tumor specimen. To validate the use of tissue microarrays for immunophenotyping, we studied a group of 59 fibroblastic tumors with variable protein expression patterns by immunohistochemistry for Ki-67, p53, and the retinoblastoma protein (pRB). Data on full tissue sections were compared to the results of one, two, and three 0.6-mm core biopsies per tumor on a tissue array. Ki-67 and p53 staining was read as two categories (positive or negative). Concordance for this staining between tissue arrays with triplicate cores per tumor and full sections were 96 and 98%, respectively. For pRB staining was read as three categories (high, moderate, or negative), where concordance was 91%. The use of three cores per tumor resulted in lower numbers of lost cases and lower nonconcordance with standard full sections as compared to one or two cores per tumor. Correlations between phenotypes and clinical outcome were not significantly different between full section and array-based analysis. Triplicate 0.6-mm core biopsies sampled on tissue arrays provide a reliable system for high-throughput expression profiling by immunohistochemistry when compared to standard full sections. Triplicate cores offer a higher rate of assessable cases and a lower rate of nonconcordant readings than one or two cores. Concordance of triplicate cores is high (96 to 98%) for two category distinction and decreases with the complexity of the phenotypes being analyzed (91%).




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
A. M. Mulligan, D. Pinnaduwage, S. B. Bull, F. P. O'Malley, and I. L. Andrulis
Prognostic Effect of Basal-Like Breast Cancers Is Time Dependent: Evidence from Tissue Microarray Studies on a Lymph Node-Negative Cohort
Clin. Cancer Res., July 1, 2008; 14(13): 4168 - 4174.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
I. S. Sarkaria, M. F. Zakowski, D. Pham, M. Hezel, M. I. Ebright, S. Chuai, E. S. Venkatraman, M. G. Kris, V. W. Rusch, and B. Singh
Epidermal Growth Factor Receptor Signaling in Adenocarcinomas With Bronchioloalveolar Components
Ann. Thorac. Surg., January 1, 2008; 85(1): 216 - 223.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Gravdal, O. J. Halvorsen, S. A. Haukaas, and L. A. Akslen
A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer
Clin. Cancer Res., December 1, 2007; 13(23): 7003 - 7011.
[Abstract] [Full Text] [PDF]

Home page
 jvdiHome page
S. M. Keller, B. C. Keller, P. Grest, C. T. Borger, and F. Guscetti
Validation of tissue microarrays for immunohistochemical analyses of canine lymphomas
J Vet Diagn Invest, November 1, 2007; 19(6): 652 - 659.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. Cohen, B. Maly, I. Simon, A. Meirovitz, E. Pikarsky, E. Zcharia, T. Peretz, I. Vlodavsky, and M. Elkin
Tamoxifen Induces Heparanase Expression in Estrogen Receptor Positive Breast Cancer
Clin. Cancer Res., July 15, 2007; 13(14): 4069 - 4077.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Rolland, S. Deen, I. Scott, L. Durrant, and I. Spendlove
Human Leukocyte Antigen Class I Antigen Expression Is an Independent Prognostic Factor in Ovarian Cancer
Clin. Cancer Res., June 15, 2007; 13(12): 3591 - 3596.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
E. Burum-Auensen, P. M. De Angelis, A. R. Schjolberg, K. L. Kravik, M. Aure, and O. P. F. Clausen
Subcellular Localization of the Spindle Proteins Aurora A, Mad2, and BUBR1 Assessed by Immunohistochemistry
J. Histochem. Cytochem., May 1, 2007; 55(5): 477 - 486.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
G. Fons, S. M Hasibuan, J. van der Velden, and F. J W ten Kate
Validation of tissue microarray technology in endometrioid cancer of the endometrium
J. Clin. Pathol., May 1, 2007; 60(5): 500 - 503.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. S. Lam, A. J. Pantuck, A. S. Belldegrun, and R. A. Figlin
Protein Expression Profiles in Renal Cell Carcinoma: Staging, Prognosis, and Patient Selection for Clinical Trials
Clin. Cancer Res., January 15, 2007; 13(2): 703s - 708s.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
A. Zimpfer, S. Schonberg, A. Lugli, C. Agostinelli, S. A Pileri, P. Went, and S. Dirnhofer
Construction and validation of a bone marrow tissue microarray
J. Clin. Pathol., January 1, 2007; 60(1): 57 - 61.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
Y. Su, M. J. Shrubsole, R. M. Ness, Q. Cai, N. Kataoka, K. Washington, and W. Zheng
Immunohistochemical Expressions of Ki-67, Cyclin D1, {beta}-Catenin, Cyclooxygenase-2, and Epidermal Growth Factor Receptor in Human Colorectal Adenoma: A Validation Study of Tissue Microarrays.
Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1719 - 1726.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. L. Wang, T.-T. Wu, E. Resetkova, H. Wang, A. M. Correa, W. L. Hofstetter, S. G. Swisher, J. A. Ajani, A. Rashid, S. R. Hamilton, et al.
Expression of Annexin A1 in Esophageal and Esophagogastric Junction Adenocarcinomas: Association with Poor Outcome
Clin. Cancer Res., August 1, 2006; 12(15): 4598 - 4604.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
I. M. Bachmann, O. J. Halvorsen, K. Collett, I. M. Stefansson, O. Straume, S. A. Haukaas, H. B. Salvesen, A. P. Otte, and L. A. Akslen
EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast
J. Clin. Oncol., January 10, 2006; 24(2): 268 - 273.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. M. Bachmann, O. Straume, H. E. Puntervoll, M. B. Kalvenes, and L. A. Akslen
Importance of P-Cadherin, {beta}-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma
Clin. Cancer Res., December 15, 2005; 11(24): 8606 - 8614.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Anttonen, L. Unkila-Kallio, A. Leminen, R. Butzow, and M. Heikinheimo
High GATA-4 Expression Associates with Aggressive Behavior, whereas Low Anti-Mullerian Hormone Expression Associates with Growth Potential of Ovarian Granulosa Cell Tumors
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6529 - 6535.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
W. L. Ince, A. M. Jubb, S. N. Holden, E. B. Holmgren, P. Tobin, M. Sridhar, H. I. Hurwitz, F. Kabbinavar, W. F. Novotny, K. J. Hillan, et al.
Association of k-ras, b-raf, and p53 Status With the Treatment Effect of Bevacizumab
J Natl Cancer Inst, July 6, 2005; 97(13): 981 - 989.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
T. J. Belbin, B. Singh, R. V. Smith, N. D. Socci, V. B. Wreesmann, M. Sanchez-Carbayo, J. Masterson, S. Patel, C. Cordon-Cardo, M. B. Prystowsky, et al.
Molecular Profiling of Tumor Progression in Head and Neck Cancer
Arch Otolaryngol Head Neck Surg, January 1, 2005; 131(1): 10 - 18.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
I. S. Sarkaria, D. Pham, R. A. Ghossein, S. G. Talbot, M. Hezel, M. E. Dudas, M. I. Ebright, S. Chuai, N. Memoli, E. S. Venkatraman, et al.
SCCRO Expression Correlates With Invasive Progression in Bronchioloalveolar Carcinoma
Ann. Thorac. Surg., November 1, 2004; 78(5): 1734 - 1741.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
E Kay, A O'Grady, J M Morgan, S Wozniak, and B Jasani
Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing
J. Clin. Pathol., November 1, 2004; 57(11): 1140 - 1144.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
Z. Suo, K. U. Daehli, C. Fr. Lindboe, E. Borgen, A. Bassarova, and J. M. Nesland
Real-Time PCR Quantification of c-erbB-2 Gene is an Alternative for Fish in the Clinical Management of Breast Carcinoma Patients
International Journal of Surgical Pathology, October 1, 2004; 12(4): 311 - 318.
[Abstract] [PDF]

Home page
 JCOHome page
F. R. Hirsch, M. Varella-Garcia, P. A. Bunn Jr, M. V. Di Maria, R. Veve, R. M. Bremnes, A. E. Baron, C. Zeng, and W. A. Franklin
In Reply:
J. Clin. Oncol., September 1, 2004; 22(17): 3646 - 3648.
[Full Text]

Home page
 J. Clin. Pathol.Home page
A M Jubb, T Q Pham, A M Hanby, G D Frantz, F V Peale, T D Wu, H W Koeppen, and K J Hillan
Expression of vascular endothelial growth factor, hypoxia inducible factor 1{alpha}, and carbonic anhydrase IX in human tumours
J. Clin. Pathol., May 1, 2004; 57(5): 504 - 512.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
I. M. Stefansson, H. B. Salvesen, and L. A. Akslen
Prognostic Impact of Alterations in P-Cadherin Expression and Related Cell Adhesion Markers in Endometrial Cancer
J. Clin. Oncol., April 1, 2004; 22(7): 1242 - 1252.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
C. Gurrieri, P. Capodieci, R. Bernardi, P. P. Scaglioni, K. Nafa, L. J. Rush, D. A. Verbel, C. Cordon-Cardo, and P. P. Pandolfi
Loss of the Tumor Suppressor PML in Human Cancers of Multiple Histologic Origins
J Natl Cancer Inst, February 18, 2004; 96(4): 269 - 279.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
L. K. Diaz, X. Zhou, K. Welch, A. Sahin, and M. Z. Gilcrease
Chromogenic In Situ Hybridization for {alpha}6{beta}4 Integrin in Breast Cancer: Correlation with Protein Expression
J. Mol. Diagn., February 1, 2004; 6(1): 10 - 15.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
R. Simon, S. Panussis, R. Maurer, H. Spichtin, K. Glatz, C. Tapia, M. Mirlacher, A. Rufle, J. Torhorst, and G. Sauter
KIT (CD117)-Positive Breast Cancers Are Infrequent and Lack KIT Gene Mutations
Clin. Cancer Res., January 1, 2004; 10(1): 178 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Puig, P. Capodieci, M. Drobnjak, D. Verbel, C. Prives, C. Cordon-Cardo, and C. J. Di Como
p73 Expression in Human Normal and Tumor Tissues: Loss of p73{alpha} Expression Is Associated with Tumor Progression in Bladder Cancer
Clin. Cancer Res., November 15, 2003; 9(15): 5642 - 5651.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
Y. S. Choi, Y. M. Shim, S.-H. Kim, D. S. Son, H.-S. Lee, G. Y. Kim, J. Han, and J. Kim
Prognostic significance of E-cadherin and {beta}-catenin in resected stage I non-small cell lung cancer
Eur. J. Cardiothorac. Surg., September 1, 2003; 24(3): 441 - 449.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Sanchez-Carbayo, N. D. Socci, J. J. Lozano, W. Li, E. Charytonowicz, T. J. Belbin, M. B. Prystowsky, A. R. Ortiz, G. Childs, and C. Cordon-Cardo
Gene Discovery in Bladder Cancer Progression using cDNA Microarrays
Am. J. Pathol., August 1, 2003; 163(2): 505 - 516.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
P. Gibson, J. H. Gill, P. A. Khan, J. M. Seargent, S. W. Martin, P. A. Batman, J. Griffith, C. Bradley, J. A. Double, M. C. Bibby, et al.
Cytochrome P450 1B1 (CYP1B1) Is Overexpressed in Human Colon Adenocarcinomas Relative to Normal Colon: Implications for Drug Development
Mol. Cancer Ther., June 1, 2003; 2(6): 527 - 534.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. L. Wapnir, M. van de Rijn, K. Nowels, P. S. Amenta, K. Walton, K. Montgomery, R. S. Greco, O. Dohan, and N. Carrasco
Immunohistochemical Profile of the Sodium/Iodide Symporter in Thyroid, Breast, and Other Carcinomas Using High Density Tissue Microarrays and Conventional Sections
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1880 - 1888.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
Y. Hendriks, P. Franken, J. W. Dierssen, W. de Leeuw, J. Wijnen, E. Dreef, C. Tops, M. Breuning, A. Brocker-Vriends, H. Vasen, et al.
Conventional and Tissue Microarray Immunohistochemical Expression Analysis of Mismatch Repair in Hereditary Colorectal Tumors
Am. J. Pathol., February 1, 2003; 162(2): 469 - 477.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Sanchez-Carbayo, P. Capodieci, and C. Cordon-Cardo
Tumor Suppressor Role of KiSS-1 in Bladder Cancer: Loss of KiSS-1 Expression Is Associated with Bladder Cancer Progression and Clinical Outcome
Am. J. Pathol., February 1, 2003; 162(2): 609 - 617.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Sanchez-Carbayo
Use of High-Throughput DNA Microarrays to Identify Biomarkers for Bladder Cancer
Clin. Chem., January 1, 2003; 49(1): 23 - 31.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Sanchez-Carbayo, N. D. Socci, E. Charytonowicz, M. Lu, M. Prystowsky, G. Childs, and C. Cordon-Cardo
Molecular Profiling of Bladder Cancer Using cDNA Microarrays: Defining Histogenesis and Biological Phenotypes
Cancer Res., December 1, 2002; 62(23): 6973 - 6980.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Hoos, A. Nissan, A. Stojadinovic, J. Shia, C. V. Hedvat, D. H. Y. Leung, P. B. Paty, D. Klimstra, C. Cordon-Cardo, and W. D. Wong
Tissue Microarray Molecular Profiling of Early, Node-negative Adenocarcinoma of the Rectum: A Comprehensive Analysis
Clin. Cancer Res., December 1, 2002; 8(12): 3841 - 3849.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. J. Urist, C. J. Di Como, M.-L. Lu, E. Charytonowicz, D. Verbel, C. P. Crum, T. A. Ince, F. D. McKeon, and C. Cordon-Cardo
Loss of p63 Expression Is Associated with Tumor Progression in Bladder Cancer
Am. J. Pathol., October 1, 2002; 161(4): 1199 - 1206.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Ginestier, E. Charafe-Jauffret, F. Bertucci, F. Eisinger, J. Geneix, D. Bechlian, N. Conte, J. Adelaide, Y. Toiron, C. Nguyen, et al.
Distinct and Complementary Information Provided by Use of Tissue and DNA Microarrays in the Study of Breast Tumor Markers
Am. J. Pathol., October 1, 2002; 161(4): 1223 - 1233.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
K. P.H. Pritzker
Cancer Biomarkers: Easier Said Than Done
Clin. Chem., August 1, 2002; 48(8): 1147 - 1150.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. M. Bremnes, R. Veve, E. Gabrielson, F. R. Hirsch, A. Baron, L. Bemis, R. M. Gemmill, H. A. Drabkin, and W. A. Franklin
High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non-Small-Cell Lung Cancer
J. Clin. Oncol., May 15, 2002; 20(10): 2417 - 2428.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
D Gancberg, A Di Leo, G Rouas, T Jarvinen, A Verhest, J Isola, M J Piccart, and D Larsimont
Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma
J. Clin. Pathol., April 1, 2002; 55(4): 315 - 317.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
O. Straume and L. A. Akslen
Importance of Vascular Phenotype by Basic Fibroblast Growth Factor, and Influence of the Angiogenic Factors Basic Fibroblast Growth Factor/Fibroblast Growth Factor Receptor-1 and Ephrin-A1/EphA2 on Melanoma Progression
Am. J. Pathol., March 1, 2002; 160(3): 1009 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Stojadinovic, R. A. Ghossein, A. Hoos, A. Nissan, D. Marshall, M. Dudas, C. Cordon-Cardo, D. P. Jaques, and M. F. Brennan
Adrenocortical Carcinoma: Clinical, Morphologic, and Molecular Characterization
J. Clin. Oncol., February 15, 2002; 20(4): 941 - 950.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. J. Di Como, M. J. Urist, I. Babayan, M. Drobnjak, C. V. Hedvat, J. Teruya-Feldstein, K. Pohar, A. Hoos, and C. Cordon-Cardo
p63 Expression Profiles in Human Normal and Tumor Tissues
Clin. Cancer Res., February 1, 2002; 8(2): 494 - 501.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Hoos, A. Stojadinovic, B. Singh, M. E. Dudas, D. H. Y. Leung, A. R. Shaha, J. P. Shah, M. F. Brennan, C. Cordon-Cardo, and R. Ghossein
Clinical Significance of Molecular Expression Profiles of Hurthle Cell Tumors of the Thyroid Gland Analyzed via Tissue Microarrays
Am. J. Pathol., January 1, 2002; 160(1): 175 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. G. Chung, E. Provost, E. P. Kielhorn, L. A. Charette, B. L. Smith, and D. L. Rimm
Tissue Microarray Analysis of {beta}-Catenin in Colorectal Cancer Shows Nuclear Phospho-{beta}-catenin Is Associated with a Better Prognosis
Clin. Cancer Res., December 1, 2001; 7(12): 4013 - 4020.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Polsky, B. C. Bastian, C. Hazan, K. Melzer, J. Pack, A. Houghton, K. Busam, C. Cordon-Cardo, and I. Osman
HDM2 Protein Overexpression, but not Gene Amplification, is Related to Tumorigenesis of Cutaneous Melanoma
Cancer Res., October 1, 2001; 61(20): 7642 - 7646.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. R. Srinivas, S. Srivastava, S. Hanash, and G. L. Wright Jr
Proteomics in Early Detection of Cancer
Clin. Chem., October 1, 2001; 47(10): 1901 - 1911.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology.